We are live on ! Find out more
SILK

Silk Road Medical, Inc. Common Stock

Delisted

SILK was delisted on the 16th of September, 2024.

130 hedge funds and large institutions have $1.18B invested in Silk Road Medical, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 10

247% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 17

116% more call options, than puts

Call options by funds: $2.05M | Put options by funds: $948K

37% more capital invested

Capital invested by funds: $859M → $1.18B (+$322M)

29% more funds holding

Funds holding: 101130 (+29)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
130
Holders Change
+29
Holders Change %
+28.71%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
44
Increased
59
Reduced
17
Closed
10
Calls
$2.05M
Puts
$948K
Net Calls
+$1.1M
Net Calls Change
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
SB
76
Strategic Blueprint
Georgia
$567K +$491K +14,032 New
PCA
77
Personal Capital Advisors
California
$548K +$475K +13,566 New
ML
78
McAdam LLC
Pennsylvania
$475K +$412K +11,771 New
SBH
79
Segall Bryant & Hamill
Illinois
$471K -$32.6K -932 -7%
JP Morgan Chase
80
JP Morgan Chase
New York
$408K +$136K +3,879 +62%
AIG
81
American International Group
New York
$407K +$94K +2,684 +36%
Tudor Investment Corp
82
Tudor Investment Corp
Connecticut
$406K +$352K +10,046 New
MCM
83
Mengis Capital Management
Oregon
$405K +$351K +10,035 New
NAM
84
Nexpoint Asset Management
Texas
$404K
WMSA
85
Weiss Multi-Strategy Advisers
New York
$404K
ZP
86
Zimmer Partners
New York
$404K
PPA
87
Parametric Portfolio Associates
Washington
$402K +$31.9K +911 +10%
Citigroup
88
Citigroup
New York
$398K +$245K +6,999 +246%
HSBC Holdings
89
HSBC Holdings
United Kingdom
$389K +$335K +9,570 New
UBS Group
90
UBS Group
Switzerland
$380K +$316K +9,032 +2,544%
Franklin Resources
91
Franklin Resources
California
$380K +$330K +9,421 New
FAM
92
Fred Alger Management
New York
$373K +$43.2K +1,233 +15%
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$303K +$28.7K +820 +12%
RG
94
Rathbones Group
United Kingdom
$302K
MIM
95
MetLife Investment Management
New Jersey
$302K +$61.2K +1,749 +31%
CSS
96
Cubist Systematic Strategies
Connecticut
$293K +$254K +7,265 New
VOYA Investment Management
97
VOYA Investment Management
Georgia
$293K +$254K +7,266 New
PMG
98
ProVise Management Group
Florida
$254K +$220K +6,284 New
RIA
99
Realta Investment Advisors
Delaware
$251K +$26.3K +750 +12%
BAM
100
Bullseye Asset Management
Colorado
$242K +$210K +6,000 New

SILK Hedge Fund Activity: Q4 2019 in Review

130 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q4 2019, worth a combined $1.18B — up 37% from $859M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new SILK positions and 10 closed out — a net gain of 34 holders — while 59 added to existing stakes and 17 trimmed.

The largest buyer was Wells Fargo, adding an estimated $43.9M. The largest seller was Warburg Pincus, cutting an estimated $52.5M.

  • 130 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q4 2019, up from 101 in Q3 2019.
  • Funds reported $1.18B of Silk Road Medical, Inc. Common Stock stock for Q4 2019, up 37% quarter-over-quarter.
  • 44 funds opened new Silk Road Medical, Inc. Common Stock positions in Q4 2019 and 10 closed out, a net change of +34 holders.
  • The largest Silk Road Medical, Inc. Common Stock buyer in Q4 2019 was Wells Fargo, an estimated $43.9M added.
  • The largest Silk Road Medical, Inc. Common Stock seller in Q4 2019 was Warburg Pincus, an estimated $52.5M sold.

Based on aggregated 13F filings for Q4 2019.